🇺🇸 FDA
Patent

US 8680150

Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors

granted A61PA61P25/00A61P31/00

Quick answer

US patent 8680150 (Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors) held by Ligand Pharmaceuticals Incorporated expires Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Mar 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P25/00, A61P31/00, A61P37/00, A61P9/00